Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. INBIOGEN CO.,Ltd
  6. News
  7. Summary
    A101140   KR7101140002

INBIOGEN CO.,LTD

(A101140)
  Report
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

INBIOGEN CO.,Ltd announced that it has received KRW 15 billion in funding

08/31/2021 EDT

On August 31, 2021, INBIOGEN CO.,Ltd closed the transaction. The company issued KRW 15,000,000,000 in the transaction.


© S&P Capital IQ 2021
All news about INBIOGEN CO.,LTD
08/31INBIOGEN CO.,Ltd announced that it has received KRW 15 billion in funding
CI
05/31INBIOGEN CO.,Ltd announced that it has received KRW 23.300002 billion in funding from B..
CI
2020Vidente Co., Ltd. announced that it has received KRW 40 billion in funding from INBIOGE..
CI
2020INBIOGEN CO.,Ltd announced that it expects to receive KRW 25.00000128 billion in fundin..
CI
2020BTONE CO.,Ltd announced that it has received KRW 20 billion in funding
CI
2020INBIOGEN CO.,Ltd announced that it expects to receive KRW 20 billion in funding
CI
2020Haim Bio Co.,Ltd. announced that it has received KRW 4.999998996 billion in funding fro..
CI
2020Vidente Co., Ltd. announced that it expects to receive KRW 40 billion in funding from B..
CI
2020Haim Bio Co.,Ltd. announced that it expects to receive KRW 4.999998996 billion in fundi..
CI
2020Bucket Studio Co., Ltd. cancelled the acquisition of 22.53% stake in BTONE CO.,Ltd from..
CI
More news
Financials
Sales 2020 10 218 M 8,67 M 8,67 M
Net income 2020 -45 078 M -38,3 M -38,3 M
Net cash 2020 74 263 M 63,0 M 63,0 M
P/E ratio 2020 -4,81x
Yield 2020 -
Capitalization 179 B 152 M 152 M
EV / Sales 2019 9,91x
EV / Sales 2020 17,5x
Nbr of Employees 41
Free-Float 56,8%
Chart INBIOGEN CO.,LTD
Duration : Period :
INBIOGEN CO.,Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INBIOGEN CO.,LTD
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers and Directors
Sang-Jun Lee Co-Chief Executive Officer & Director
Sang-Woo Kim Co-Chief Executive Officer & Director
In-Seop Oh Independent Director
Kang-Ho Kim Independent Director
Jeong-Hoon Lee Non-Executive Director